Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Safety study for bepotastine besilate ophthalmic solution in normal volunteers

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Bepotastine besilate; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Subjects must be at least 3 years of age, and have ocular health within normal limits

Exclusion Criteria:

• No active ocular disease